NTRR Targets Colorado as Ideal Market to Test New Cannabis Cultivation Technology

TAMPA, Fla.--()--Neutra Corp. (OTCBB: NTRR), a provider of innovative all-natural wellness solutions, and joint venture partner Surface to Air Solutions (S2O2) are working to build new partnerships with cannabis cultivators in Colorado to test out and demonstrate the company’s suite of market-ready agricultural technologies.

“Colorado has quickly become the cutting edge of cannabis-related product development and marketing,” said NTRR CEO Chris Brown. “We want NTRR to be a leader in this emerging industry, so Colorado is where we need to be right now. We’re very excited about the tech breakthroughs that we plan to introduce into the cultivation community there.”

NTRR is helping to market and develop antimicrobial products created by S202 to eliminate germs and odors from doctors’ offices, gyms, locker rooms and other at-risk human environments. These products’ unique properties, however, make them a powerful tool in indoor agriculture, as well. When applied to surfaces, S2O2’s environmentally friendly formulas form an invisible, long-lasting coating that actively protects surfaces from the build-up of organic matter—including bacteria, molds, germs and allergens.

The joint venture is seeking cultivation partners in Colorado ready to see the results that are possible using Nano Gro—a colloidal emulsion that accelerates plants’ photosynthesis process, increases their production of sugar and protects them against bacteria, pests and mildew—as well as a hydroxyl generator to improve air quality.

The products are already being tested at growing facilities in California and Canada.

About Neutra Corp.

Neutra Corp. is a healthy lifestyle company that specializes in the development and marketing of natural wellness solutions, including cannabis-related products. By providing a variety of new technologies designed to ensure safer, more reliable access to cannabis in approved markets, Neutra Corp. plans to compete alongside GW Pharmaceuticals (OTCBB: GWPRF), INSYS Therapeutics, Inc. (NASDAQ: INSY) and ENDEXX Corp. (OTCBB: EDXC), delivering technological advancements in the cultivation and processing of cannabis in approved markets. For investing information and performance data, please visit www.neutracorp.com.

Notice Regarding Forward-Looking Statements

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words “believes,” “expects,” “anticipate” or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone’s past success, either financial or strategic, is no guarantee of success. This news release speaks as of the date first set forth above and the Company assumes no responsibility to update the information included herein for events occurring after the date hereof.

Contacts

Neutra Corp.
Chris Brown, 813-367-2041
President and CEO
info@neutracorp.com

Release Summary

NTRR seeks out new product testing opportunities in the Colorado cannabis cultivation market.

Contacts

Neutra Corp.
Chris Brown, 813-367-2041
President and CEO
info@neutracorp.com